In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy
Jin Qu, Yuan Wang, Chuxiao Xiong, Mingxue Wang, Xingdao He, Weibin Jia, Cheuk Yin Li, Tianlong Zhang, Zixun Wang, Wei Li, Becki Yi Kuang, Peng Shi · 2024
Read In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy by Jin Qu, Yuan Wang, Chuxiao Xiong, Mingxue Wang, Xingdao He, Weibin Jia, Cheuk Yin Li, Tianlong Zhang, Zixun Wang, Wei Li, Becki Yi Kuang, Peng Shi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11589603.txt.
Description
Jin Qu and co-authors edit T-cells inside a mouse's lymph nodes, without ever taking the cells out, in a 2024 study. Checkpoint blockade drugs free the immune system against cancer but help few patients and can misfire. The team built a conductive hydrogel electrode system that pulses CRISPR machinery into lymph node T-cells, deleting the PD-1 brake gene right where the cells live.
The edited cells multiplied, infiltrated melanoma tumors in several-fold greater numbers, and strengthened both cellular and antibody immunity. Tumors shrank, spread and recurrence were prevented, and survival lengthened across mouse melanoma models. The authors frame the work as proof of concept for direct in-body T-cell engineering. They also suggest the local editing route could generalize to harder human diseases, once delivery and safety mature.
Catalog record
| CREATOR | Jin Qu, Yuan Wang, Chuxiao Xiong, Mingxue Wang, Xingdao He, Weibin Jia, Cheuk Yin Li, Tianlong Zhang, Zixun Wang, Wei Li, Becki Yi Kuang, Peng Shi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |